​

Verrica Pharmaceuticals (VRCA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Verrica Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$7.57M

Latest Revenue (Q)

$-1.86M

Main Segment (Y)

Product

Verrica Pharmaceuticals Revenue by Period

Verrica Pharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$7.57M47.66%
2023-12-31$5.12M-43.27%
2022-12-31$9.03M-24.73%
2021-12-31$12.00M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

Verrica Pharmaceuticals generated $7.57M in revenue during NA 2024, up 47.66% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$-1.86M-136.02%
2024-06-30$5.18M35.31%
2024-03-31$3.83M92.45%
2023-12-31$1.99M-31.85%
2023-09-30$2.92M1502.75%
2023-06-30$182.00K391.89%
2023-03-31$37.00K-45.59%
2022-12-31$68.00K-99.18%
2022-09-30$8.32M3787.38%
2022-06-30$214.00K-50.35%
2022-03-31$431.00K-103.59%
2021-12-31$-12.00M100.00%
2021-09-30-100.00%
2021-06-30--100.00%
2021-03-31$12.00M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

Verrica Pharmaceuticals generated $-1.86M in revenue during Q3 2024, up -136.02% compared to the previous quarter, and up -1024.73% compared to the same period a year ago.

Verrica Pharmaceuticals Revenue Breakdown

Verrica Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23
Collaboration$992.00K$466.00K
Product$6.57M$4.66M

Verrica Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (86.89%), and Collaboration (13.11%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Jun 24Mar 24
Collaboration$29.00K$84.00K$285.00K$594.00K
Product$315.00K$-1.86M$4.89M$3.23M

Verrica Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product (91.57%), and Collaboration (8.43%).

Verrica Pharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ASNDAscendis Pharma$266.72M$95.89M
ARQTArcutis Biotherapeutics$196.54M$30.86M
FENCFennec Pharmaceuticals$47.54M$6.97M
VRNAVerona Pharma$42.28M$5.62M
ETONEton Pharmaceuticals$39.01M$10.32M
CNTBConnect Biopharma$26.03M-
IVAInventiva$17.48M$2.73M
NUVBNuvation Bio$7.87M$727.00K
VRCAVerrica Pharmaceuticals$7.57M$-1.86M
CRNXCrinetics Pharmaceuticals$1.04M-
EWTXEdgewise Therapeutics--
ABOSAcumen Pharmaceuticals--
PLRXPliant Therapeutics--
LRMRLarimar Therapeutics--
ELDNEledon Pharmaceuticals--
VIGLVigil Neuroscience--

VRCA Revenue FAQ

What is Verrica Pharmaceuticals’s yearly revenue?

Verrica Pharmaceuticals's yearly revenue for 2024 was $7.57M, representing an increase of 47.66% compared to 2023. The company's yearly revenue for 2023 was $5.12M, representing a decrease of -43.27% compared to 2022. VRCA's yearly revenue for 2022 was $9.03M, representing a decrease of -24.73% compared to 2021.

What is Verrica Pharmaceuticals’s quarterly revenue?

Verrica Pharmaceuticals's quarterly revenue for Q3 2024 was $-1.865M, a -136.02% decrease from the previous quarter (Q2 2024), and a -163.94% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $5.18M, a 35.31% increase from the previous quarter (Q1 2024), and a 2744.51% increase year-over-year (Q2 2023). VRCA's quarterly revenue for Q1 2024 was $3.83M, a 92.45% increase from the previous quarter (Q4 2023), and a 10240.54% increase year-over-year (Q1 2023).

What is Verrica Pharmaceuticals’s revenue growth rate?

Verrica Pharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was -16.23%, and for the last 5 years (2020-2024) was 0%.

What are Verrica Pharmaceuticals’s revenue streams?

Verrica Pharmaceuticals's revenue streams in c 24 are Collaboration, and Product. Collaboration generated $992K in revenue, accounting 13.11% of the company's total revenue, up 112.88% year-over-year. Product generated $6.57M in revenue, accounting 86.89% of the company's total revenue, up 41.13% year-over-year.

What is Verrica Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Verrica Pharmaceuticals was Product. This segment made a revenue of $6.57M, representing 86.89% of the company's total revenue.